Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol

Overview of attention for article published in Journal of the American Heart Association, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 7 news outlets
twitter: 30 X users

facebook: 1 Facebook page
f1000: 1 research highlight platform

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 7 news stories from 7 outlets.

News story from Finanz Nachrichten on Wednesday 22 May 2024

Finanz Nachrichten, 22 May 2024

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Crwe World, 22 May 2024

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular…

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Finanzen.ch, 22 May 2024

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular…

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Yahoo! Finance USA, 22 May 2024

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.